| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/06/2003 | EP1333034A1 Use of angiotensin II analogs in tissue repair |
| 08/06/2003 | EP1333028A1 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence |
| 08/06/2003 | EP1332764A1 A mucoadhesive thermoresponsive medicament-carrier composition |
| 08/06/2003 | EP1332757A1 Efavirenz compressed tablet formulation |
| 08/06/2003 | EP1332755A1 Taxol liposome composition for treatment of cancer and preparation thereof |
| 08/06/2003 | EP1332754A1 Material-releasing carrier |
| 08/06/2003 | EP1332366A1 Methods for the treatment of cellular proliferative disorders |
| 08/06/2003 | EP1332220A2 Oligonucleotide - facilitated coalescence |
| 08/06/2003 | EP1332206A1 Recombinant alpha-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 08/06/2003 | EP1332170A1 Method for producing microspherical crystallites from linear polysaccharides, corresponding microspherical crystallites and the use thereof |
| 08/06/2003 | EP1332145A1 Process for formulation of antibiotic compounds |
| 08/06/2003 | EP1331972A2 Pharmaceutical compositions |
| 08/06/2003 | EP1331960A2 Device and method for the cessation of smoking |
| 08/06/2003 | EP1331948A2 Pharmaceutical composition containing honey for the treatment of wounds |
| 08/06/2003 | EP1331947A2 Use of citric acid as antimicrobial agent or enhancer or as anticancer agent |
| 08/06/2003 | EP1331933A2 The use of tiagabine for treatment of diabetic neuropathy and migraine |
| 08/06/2003 | EP1331929A1 Transdermal drug delivery system with improved water absorbability and adhesion properties |
| 08/06/2003 | EP1331928A2 Particle formation methods and their products |
| 08/06/2003 | EP1331927A1 Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid |
| 08/06/2003 | EP1331924A2 Use of carotenoids for treating ageing symptoms |
| 08/06/2003 | EP1331923A2 Use of the association of at least an plant extract of genus rosmarinus and of at least a carotenoid |
| 08/06/2003 | EP1331913A2 Cubic liquid crystalline compositions and methods for their preparation |
| 08/06/2003 | EP1331902A2 Improved ophthalmic and contact lens solutions containing forms of vitamin b |
| 08/06/2003 | EP1289364A4 Stable gabapentin containing more than 2o ppm of chlorine ion |
| 08/06/2003 | EP1200070B1 Ambroxol-containing lozenge |
| 08/06/2003 | EP1187838B1 Thiazolopyrimidines useful as TNF-Alpha inhibitors |
| 08/06/2003 | EP1162945B1 Particle based vaccine composition |
| 08/06/2003 | EP1140152B1 Method to produce inactivated w/o emulsion adjuvated vaccines |
| 08/06/2003 | EP1126846B1 Use of a nicotine receptor agonist for the manufacture of a medicament for the treatment of obsessive compulsive disorder |
| 08/06/2003 | EP1117440B1 Pharmaceutical compositions containing paclitaxel |
| 08/06/2003 | EP1105102B8 Pharmaceutical composition for injection based on a pharmaceutically acceptable clopidogrel or ticlopidin salt |
| 08/06/2003 | EP1087800B1 Implantable medical device having anti-infective and contraceptive properties |
| 08/06/2003 | EP1080060B1 Crystallization of xylitol, crystalline xylitol product and use thereof |
| 08/06/2003 | EP1077684B1 Effervescent preparations |
| 08/06/2003 | EP1069896B1 Carvedilol-galenics |
| 08/06/2003 | EP1066027B1 Pharmaceutical composition of topiramate |
| 08/06/2003 | EP1062952B1 Bubbling enteric preparations |
| 08/06/2003 | EP1044064B1 Device for coating granules to be administered orally |
| 08/06/2003 | EP1032374B1 Spheroids, preparation method and pharmaceutical compositions |
| 08/06/2003 | EP1030734B1 Encapsulate of active material in alginate matrix |
| 08/06/2003 | EP1030655B1 Low temperature coatings |
| 08/06/2003 | EP1015570A4 Fibrin microbeads and uses thereof |
| 08/06/2003 | EP1005328B1 Composition comprising finely divided, crystalline particles of budesonide |
| 08/06/2003 | EP1003567B1 TEMPERATURE-CONTROLLED pH-DEPENDANT FORMATION OF IONIC POLYSACCHARIDE GELS |
| 08/06/2003 | EP0973499B1 Diffusional implantable delivery system |
| 08/06/2003 | EP0963161B1 Sugar-free dragee chewing sweets |
| 08/06/2003 | EP0948316B1 Agent for producing a long-lasting saturation effect |
| 08/06/2003 | EP0906086B1 Skin wash composition |
| 08/06/2003 | EP0806949B1 New pharmaceutical composition containing trimebutine and preparation process |
| 08/06/2003 | EP0702563B1 Compositions and methods for treating cancer and hyperproliferative disorders |
| 08/06/2003 | EP0701449B1 Process for the preparation of an oral solid dosage form containing diclofenac |
| 08/06/2003 | CN2564158Y Anti-inflammatory plaster |
| 08/06/2003 | CN1434870A Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/06/2003 | CN1434829A Processes for preparing clarithromycin polymorphs and novel polymorph IV |
| 08/06/2003 | CN1434719A Preparation capable of mobilization of activity |
| 08/06/2003 | CN1434713A Sustained-release formulation of a cyclooxygenase-2 inhibitor |
| 08/06/2003 | CN1434706A Compounds and methods for modulating cerebral anyloid angiopathy |
| 08/06/2003 | CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers |
| 08/06/2003 | CN1434704A System and method for extended delivery of therapeutic agent with its receptor loading dose |
| 08/06/2003 | CN1434703A Delayed release compositions and combinations |
| 08/06/2003 | CN1434701A Y-IFN liquid-droplet aerosol and method |
| 08/06/2003 | CN1434697A Hair growth stimulant compositions with sustained action |
| 08/06/2003 | CN1434691A Tissue sensitizing compounds for females and methods and apparatus for the delivery of these compounds |
| 08/06/2003 | CN1433810A Compound liquorice lozenge and preparation process thereof |
| 08/06/2003 | CN1433808A Compound prunella spike capsule and preparation process thereof |
| 08/06/2003 | CN1433799A Method for producing coated pill of health care products used for reducing weight and regulating blood-lipid |
| 08/06/2003 | CN1433789A Health care adhesive plaster capable of accelerating blood circulation and discharging toxicity |
| 08/06/2003 | CN1433785A Formula of adhesive plaster for treating painful swelling |
| 08/06/2003 | CN1433781A Wanli ointment |
| 08/06/2003 | CN1433777A Cerium carried (Ôàó) rectorite anti-inflammatory and bacteriostatic medicine and preparation process thereof |
| 08/06/2003 | CN1433768A Flavone Hippophaes slow-released, control-redeased agent |
| 08/06/2003 | CN1433765A Sodium foscarnet froozen dry preparation and process for preparing same |
| 08/06/2003 | CN1433764A Sodium foscarnet gel preparation and preparation process thereof |
| 08/06/2003 | CN1433763A Enoxacin preparation and preparation process thereof |
| 08/06/2003 | CN1433761A Piperazine ferulate slow-released, control-released agent |
| 08/06/2003 | CN1433760A Oral tablet containing 2-ÒÇö(4-methoxy-3-methyl)-2-pyridylÒÇòmethylsulfonyl-5-(1-H-pyrrole-1-group)-1H-benzimidazole |
| 08/06/2003 | CN1433759A Slow-released composition of ondansetron gydrochloride |
| 08/06/2003 | CN1433758A Use of potassium dehydroandrographolide succinate in preparing external used medicine |
| 08/06/2003 | CN1433757A Use of potassium dehydroandrographolide succinate in preparing oral cavity local applied medicine for treating plaryngitis |
| 08/06/2003 | CN1117085C Sparfloxacin salt and synthesis method and use thereof |
| 08/06/2003 | CN1116903C Far-infrared magnetic health-care adhesive plaster |
| 08/06/2003 | CN1116901C Powdery pharmaceutical preparation and method of manufacturing same |
| 08/06/2003 | CN1116900C Solubilizing agent and external preparation containing the same |
| 08/06/2003 | CN1116899C Oral pharmaceutical dosage forms comprising a proton pump inhibitorand NSAID |
| 08/06/2003 | CN1116897C Parathyroid hormone medicine coposition |
| 08/06/2003 | CN1116892C Bagged blood circulation-activating and obstruction-dredgnig granule and its preparation |
| 08/06/2003 | CN1116890C Medicine for treating hepatitis B |
| 08/06/2003 | CN1116886C Process for preparing Chinese-medicinal pills containing borneol |
| 08/06/2003 | CN1116884C Capsule for treating angiocardiopathy, cholecystitis and cholelithiasis |
| 08/06/2003 | CN1116877C Carboprost methylate preparation able to be absorbed via oral musoca and its preparing process |
| 08/06/2003 | CN1116875C Taxual-lipid composition and its preparing process |
| 08/06/2003 | CN1116874C TPA injection and its producing technology |
| 08/06/2003 | CN1116869C Use of THF-alpha-antagonist for treating neurogenic skin redness |
| 08/06/2003 | CN1116868C Concentrated granule medicine of famous decoction formulation and its preparation process |
| 08/06/2003 | CN1116867C Ointment suppository contained in plastic bag and mfg. method thereof |
| 08/06/2003 | CN1116808C Chewing gum containing physiological cooling agents |
| 08/05/2003 | US6602995 The reaction product of an alkali cellulose with a hydroxypropylating agent is granulated and the resulting granular material is neutralized with acid |
| 08/05/2003 | US6602991 Solution composed of sodium chloride, monobasic and dibasic sodium phosphate dissolved in water; agitation, filtering and drying; use in the treatment for cholera and as antidote for ferrous ion intoxication |
| 08/05/2003 | US6602975 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| 08/05/2003 | US6602952 Hydrogels derived from chitosan and poly(ethylene glycol) or related polymers |